| Literature DB >> 31684875 |
Jun Sakai1,2,3, Kazuhito Imanaka4, Masahiro Kodana5, Kana Ohgane5, Susumu Sekine6, Kei Yamamoto2, Yusuke Nishida2, Toru Kawamura5, Takahiro Matsuoka4, Shigefumi Maesaki3, Hideaki Oka2, Hideaki Ohno7.
Abstract
BACKGROUND: Capnocytophaga canimorsus is a gram-negative bacterium and an oral commensal in dogs and cats, but occasionally causes serious infections in humans. Septicemia is one of the most fulminant forms, but diagnosis of C. canimorsus infection is often difficult mainly because of its very slow growth. C. canimorsus infective endocarditis (IE) is rare and is poorly understood. Since quite a few strains produce β-lactamase, antimicrobial susceptibility is pivotal information for adequate treatment. We herein report a case with C. canimorsus IE and the results of drug susceptibility test. CASEEntities:
Keywords: Capnocytophaga canimorsus; Ceftriaxone; Drug susceptibility test; Infective endocarditis
Mesh:
Substances:
Year: 2019 PMID: 31684875 PMCID: PMC6827180 DOI: 10.1186/s12879-019-4492-3
Source DB: PubMed Journal: BMC Infect Dis ISSN: 1471-2334 Impact factor: 3.090
Laboratory data on admission
| (A) Peripheal blood data | |
| Peripheral Blood | |
| WBC | 10,500 /μL |
| Neut | 59.8% |
| Lymp | 31.1% |
| Mono | 4.9% |
| Eosi | 3.9% |
| Baso | 0.3% |
| RBC | 430 × 106/μL |
| HCT | 42.0% |
| Hb | 11.7 g/dL |
| MCV | 97.7 fL |
| MCH | 32.3 pg |
| MCHC | 33.1 pg |
| PLT | 22.4 × 106/μL |
| (B) Chemistry data | |
| Chemistry | |
| TP | 6.3 g/dL |
| ALB | 4.0 g/dL |
| AST | 126 IU/L |
| ALT | 101 IU/L |
| LDH | 179 IU/L |
| γGTP | 24 U/L |
| BUN | 15 mg/dL |
| Cr | 0.71 mg/dL |
| Na | 142 mEq/L |
| K | 3.3 mEq/L |
| Cl | 107 mEq/L |
| CRP | 9.0 mg/dL |
| BNP | 689.2 pg/mL |
WBC white blood cells, Neut neutrophils, Lymp lymphocytes, Mono monocytes, Eosi eosinophils, Baso basophils, RBC red blood cells, HCT hematocrit, Hb hemoglobin, MCV mean cell volume, MCH mean corpuscular hemoglobin, MCHC mean corpuscular hemoglobin concentration, PLT platelet counts, TP total protein, ALB albumin, AST aspartate aminotransferase, ALT alanine aminotransferase, LDH lactate dehydrogenase (upper limited: 211 IU/L), γ-GTP γ-glutamyl transpeptidase, BUN blood urea nitrogen, Cr creatinine, Na sodium, K potassium, Cl chlorine, CRP C-reaction peptide, BNP brain natriuretic protein
Fig. 1Echocardiogram showing moderate-to-severe aortic valve regurgitation and vegetation of 17-mm in size
Fig. 2Capnocytophaga-like gram-negative bacilli on the aortic valve (× 1000)
Drug susceptibility shown by disk diffusion method
| Antimicrobial Agents | Inhibition Zone (mm) |
|---|---|
| Penicillin G | 32 |
| Sulbactam/Ampicillin | 36 |
| Tazobactam/Piperacillin | 38 |
| Ceftriaxone | 20 |
| Meropenem | 36 |
| Gentamycin | < 6 |
| Amikacin | < 6 |
| Levofloxacin | 34 |
| Minocycline | 40 |
| Sulfamethoxazole/Trimethoprim | < 6 |
| Clarithromycin | 38 |
| Clindamycin | 34 |
Infective endocarditis caused by Capnocytophaga canimorsus in literature
| No | Age/Sex | Animal contact | Underlying disease | Infected valve | Surgery (Methods) | Antibiotics | Complications | Outcome | References |
|---|---|---|---|---|---|---|---|---|---|
| 1 | ND | Dog | ND | A | Yes (ND) | ND | ND | D | [ |
| 2 | ND | ND | ND | A | No | ND | ND | S | |
| 3 | ND | ND | ND | M | No | ND | ND | S | |
| 4 | 64/M | Dog | ND | T, A | No | Penicillin + Erythromycin | ND | D | |
| 5 | 59/F | ND | CLL, Atrial myxoma, Steroid use | T | Yes (ND) | Cephalothin + Gentamicin | ND | D | |
| 6 | 39/M | Dog | Alcohol abuse | M | No | Ampicillin + Tobramycin | Glomerulonephritis. | S | |
| 7 | 24/M | Dog | None | A | No | Penicillin | ND | S | |
| 8 | 47/M | Dog | Alcohol abuse | T | Yes (ND) | Vancomycin + Gentamicin | ND | S | |
| 9 | 56/M | Dog | None | T | No | Penicillin + Gentamicin | ND | S | |
| 10 | 52/M | Dog | None | A | No | Penicillin + Aztreonam | ND | S | |
| 11 | 69/F | None | COPD | T | No | Penicillin | CHF | S | |
| 12 | 63/M | Dog | AVR (Mechanical valve) | A (Periannular abscess) | Yes (AVR, Tissue valve) | Penicillin | Anemia, CHF | S | |
| 13 | 41/F | Dog | Rheumatic mitral valve disease | M | Yes (MVR, Mechanical valve) | Ceftriaxone | ND | S | [ |
| 14 | 42/M | Dog | Alcohol abuse | A | Yes (AVR, Mechanical valve) | Ceftriaxon + Gentamicin | ND | S | [ |
| 15 | 55/M | Dog | COPD, Alcohol abuse, Intravenous drug user | A (Periannular abscess), T | Yes (AVR, Mechanical valve), (Aortoplasty) (Tricuspid valve repair) | Meropenem+ Ciprofloxacin | ND | S | [ |
| 16 | 65/M | None | Dislipidemia | A (Periannular abscess) | Yes (Aortic root replacement, Mechanical valve) | Ampicillin + Gentamicin | Anemia, Renal insufficiency | S | [ |
| 17 | 73/M | Dog | AVR (Mechanical valve), Diabetes, Renal insufficiency | A | No | Meropenem + Ciprofloxacin | Anemia | S | [ |
| 18 | 43/M | Lion | None | A, M | Yes (AVR, Mechanical valve) (Mitral valve annuloplasty), (Coronary artery bypass grafting) | Ceftriaxone + Gentamicin + Vancomycin | None | S | [ |
ND No Data, M Male, F Female, CLL Chronic Lymphocytic Lymphoma, COPD Chronic Obstructive Pulmonary Disease, AVR Aortic valve replacement, A Aortic valve, M Mitral valve, T Tricuspid valve, MVR Mitral valve replacement, CHF Congestive heart failure, D Died, S Survived